Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that it has been selected to be added to the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution. According to a preliminary list of additions posted June 5, 2020, Trxade Group’s membership will be effective after the U.S. market opens on June 29, 2020. Russell Microcap Index membership, which remains in place for one year, ensures automatic inclusion in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index, raising Trxade Group’s visibility and public awareness within the investment community,” Suren Ajjarapu, chairman and CEO of Trxade Group, stated in the news release. “This marks an exciting capital markets milestone in the growth and trajectory of our Company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.”
To view the full press release, visit http://ibn.fm/mI5Tj
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
